HF
EGRX

HRT Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

HRT Financial’s Portfolio EGRX Stock Details EGRX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$761K Sell
2023
Q1 		$1.27M Sell
2022
Q4 		$1.78M Buy
2022
Q3 		– Sell
2022
Q2 		$683K Buy
2022
Q1 		$748K Sell
2021
Q4 		$993K Buy
2021
Q3 		$490K Buy